MiSeqDx Cystic Fibrosis 139-Variant Assay

Manufacturer Illumina

Product Image

0 Scientists have reviewed this product

Write the First Review

No Reviews

MiSeqDx Cystic Fibrosis 139-Variant Assay

  • Improved Detection Rates of CF-Causing Variants
    Detection of couples at risk increased from 72% to ~91%*
  • Higher Confidence in Test Results
    139-variant panel reduces residual risk
  • Reduced Additional Testing
    Highly accurate and reproducible sequencing technology delivers the right answer the first time

The test is intended to be used on the MiSeqDx instrument.

* Compared to current ACMG recommended panel

For In Vitro Diagnostic Use. Contact an Illumina representative for regional availability.